Skip to main content

Medication Safety

Featured Article
The FDA has issued a recall for a prescription antiarrhythmic used to treat heart rhythm issues.
AvKARE Inc. and AuroMedics Pharma have joined a number of companies voluntarily recalling ranitidine products because of contamination with the probable human carcinogen N-Nitrosodimethylamine.
Back to Top